Legislation mandating breast density reporting boosts demand for supplemental screening, finds Frost & Sullivan

MOUNTAIN VIEW, Calif. – April 14, 2016 – Nearly one in eight women in the U.S. is diagnosed with breast cancer, making it the most commonly diagnosed cancer and the second largest cause of death among American women. This vast patient pool is encouraging manufacturers of breast imaging systems to develop novel imaging technologies such as automated breast ultrasound and tomography, elastography, thermography and optical imaging systems.

Analysis from Frost & Sullivan, Analysis of the US Breast Imaging Systems Market (http://frost.ly/8b), finds the market earned revenues of $1.24 billion in 2014 and estimates this to reach $1.58 billion in 2019, at a compound annual growth rate of 5 percent.

For complimentary access to more information on this research, please visit: http://frost.ly/8c.

Many of the innovations, such as digital breast tomosynthesis and automated breast ultrasound, are aimed at the early detection of cancer in dense breast patients. Almost 45 to 50 percent of the women above the age of 40 have dense breasts, putting them at higher risk for cancer. Acknowledging this, 24 states in the U.S. introduced a legislation requiring patients with dense breast to be notified of the physiology. This resulted in a wider market for supplemental breast cancer screening exams and equipment.

“Screening programs have significantly helped decrease cancer-related mortality rates over the past 10 years,” saidFrost & Sullivan Transformational Health Consultant Poornima Srinivasan. “However, the increase in the number of women screened has only benefitted the X-ray mammography and ultrasound systems segments. The higher-end imaging systems have to prove their value to the medical community before they can be adopted on a large scale.”

Some of the more popular technologies are likely be aiding the cost-effective upgrades of 2-D systems to tomosynthesis and automated breast ultrasound. Multi-modality cancer detection protocols will continue to be sought-after and mammography is expected to remain the gold standard of breast imaging technologies.

“Meanwhile, the roll out of new technologies has triggered a wave of mergers and acquisitions, as spiraling R&D costs and the need for expertise make it necessary for companies to collaborate,” observed Srinivasan. “Participants are also hopeful of additional government support to help stimulate market growth in the short term.”

Analysis of the US Breast Imaging Systems Market is part of the Advanced Medical Technologies (https://ww3.frost.com/research/industry/healthcare/advanced-medical-technologies) Growth Partnership Service program. Frost & Sullivan’s related studies include: HIMSS 2016 – The Internet of Medical Imaging Things and Deep Learning in Medical Imaging, Evolution of Transactional Vendor-customer Relationships into Shared-risk Partnerships, Market Assessment of Value Segment Drivers in Medical Imaging Equipment, Review of Key Medical Imaging Market Trends from RSNA 2015, and Medical Imaging Making Decisive Steps towards a Value Focused Environment Download. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success.

Frost & Sullivan

For six decades, Frost & Sullivan has been world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success.

Share This
X